BR112012014159A8 - combinações terapêuticas de teobromina e um anti-histamínico - Google Patents

combinações terapêuticas de teobromina e um anti-histamínico

Info

Publication number
BR112012014159A8
BR112012014159A8 BR112012014159A BR112012014159A BR112012014159A8 BR 112012014159 A8 BR112012014159 A8 BR 112012014159A8 BR 112012014159 A BR112012014159 A BR 112012014159A BR 112012014159 A BR112012014159 A BR 112012014159A BR 112012014159 A8 BR112012014159 A8 BR 112012014159A8
Authority
BR
Brazil
Prior art keywords
theobromine
antihistamine
therapeutic combinations
therapy
therapeutic
Prior art date
Application number
BR112012014159A
Other languages
English (en)
Other versions
BR112012014159A2 (pt
Inventor
Brew John
Mark Bannister Robin
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of BR112012014159A2 publication Critical patent/BR112012014159A2/pt
Publication of BR112012014159A8 publication Critical patent/BR112012014159A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

combinações terapêuticas de teobromina e um anti-histamínico um agente que compreende teobromina e um anti-histamínico, como uma preparação para uso simultâneo, sequencial ou separado em terapia, especialmente na terapia da tosse.
BR112012014159A 2009-12-14 2010-12-14 combinações terapêuticas de teobromina e um anti-histamínico BR112012014159A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Publications (2)

Publication Number Publication Date
BR112012014159A2 BR112012014159A2 (pt) 2017-08-29
BR112012014159A8 true BR112012014159A8 (pt) 2017-12-26

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012014159A BR112012014159A8 (pt) 2009-12-14 2010-12-14 combinações terapêuticas de teobromina e um anti-histamínico

Country Status (17)

Country Link
EP (1) EP2512472A1 (pt)
JP (2) JP2013513652A (pt)
CN (1) CN102802625A (pt)
AU (1) AU2010332495C1 (pt)
BR (1) BR112012014159A8 (pt)
CA (1) CA2784215A1 (pt)
CO (1) CO6541638A2 (pt)
GB (1) GB0921803D0 (pt)
IL (1) IL220384A0 (pt)
MX (1) MX2012006624A (pt)
NZ (1) NZ600267A (pt)
PE (1) PE20121538A1 (pt)
RU (1) RU2012129675A (pt)
SG (2) SG10201408374WA (pt)
UA (1) UA105827C2 (pt)
WO (1) WO2011073647A1 (pt)
ZA (1) ZA201204294B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
CN103263533B (zh) * 2013-05-31 2014-11-05 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104224819B (zh) * 2014-09-18 2016-08-17 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3766885D1 (en) * 1986-04-17 1991-02-07 Alza Corp Chlorpheniramine therapie.
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
JPH10316568A (ja) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003012514A (ja) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
UY31017A1 (es) * 2007-04-11 2008-07-03 Alcon Res Ltd Uso de un inhibidor del factor &(alfa) de necrosis tumoral mas un antihistaminico para el tratamiento de la rinitis alérgica y la conjuntivitis alérgica.

Also Published As

Publication number Publication date
RU2012129675A (ru) 2014-01-27
ZA201204294B (en) 2013-02-27
AU2010332495A1 (en) 2012-06-21
CO6541638A2 (es) 2012-10-16
CA2784215A1 (en) 2011-06-23
GB0921803D0 (en) 2010-01-27
IL220384A0 (en) 2012-08-30
WO2011073647A1 (en) 2011-06-23
JP2016040280A (ja) 2016-03-24
NZ600267A (en) 2013-07-26
JP2013513652A (ja) 2013-04-22
BR112012014159A2 (pt) 2017-08-29
UA105827C2 (uk) 2014-06-25
SG181603A1 (en) 2012-07-30
CN102802625A (zh) 2012-11-28
MX2012006624A (es) 2012-10-05
AU2010332495B2 (en) 2015-01-22
AU2010332495C1 (en) 2016-02-11
EP2512472A1 (en) 2012-10-24
JP6078605B2 (ja) 2017-02-08
SG10201408374WA (en) 2015-01-29
PE20121538A1 (es) 2012-12-21

Similar Documents

Publication Publication Date Title
BR112012014159A8 (pt) combinações terapêuticas de teobromina e um anti-histamínico
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
BR112012008854A2 (pt) combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano
CR11731A (es) Composiciones y procedimientos para su preparación y uso
BR112015011933A8 (pt) Composições bacterianas sinérgicas e métodos de produção e uso das mesmas
CR11455A (es) Compuestos nuevos de hidrocarbono ciclico para el tratamiento de enfermedades
CR20130033A (es) Formulaciones de rifaximina y usos de las mismas
BR112012026801B8 (pt) conjugados de pirrolobenzodiazepina direcionados, composição farmacêutica, uso dos mesmos para tratamento de uma doença proliferativa ou autoimune e ligante de medicamento
GT201200243A (es) Derivados de pirazol como inhibidores de jak
GT201200321A (es) Derivados de heteroaril imidazolona como inhibidores de jak
CL2011002595A1 (es) Uso de una combinacion de un agente anticancerigeno y un antioxidante para tratar el cancer; y compicicion farmaceutica que comprende dicha combinacion.
BR112013017953A2 (pt) Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
BR112012022243A8 (pt) Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico
GT201200304A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
BR112012026707A2 (pt) uso de um anticorpo anti-cd20 afucosilado, composição que compreende um anticorpo anti-cd20 afucosilado e método de tratamento de pacientes que sofrem de câncer por meio da administração de um anticorpo anti-cd20 afucosilado
CO6700840A2 (es) Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia
CR11838A (es) Compuestos que contienen nitrogeno tricíclico y su uso como antibacterianos
BR112012011227A2 (pt) teobromina e agente combinado com outro antitussígeno não opióide e seu uso terapêutico
BR112015000616A2 (pt) tratamento da esclerose múltipla com combinação de laquinimode e fampridina
CL2012003265A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo.
BR112012011224A2 (pt) teobromina e agente combinado com um opióide antitussígeno e seu uso terapêutico
ECSP12012132A (es) Combinación de teobromina con un descongestivo y su uso para el tratamiento de la tos
GT200800167A (es) Inhibidores de pai-1 para tratamiento de afecciones musculares
ECSP10010464A (es) Uso de ranolazina para el tratamiento de enfermedades cardiovasculares

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.